Smith, Kelly A.
Lin, Allen H.
Stevens, Alexander H.
Yu, S. Michael
Weiss, Jeffrey A.
Timmins, Lucas H. https://orcid.org/0000-0002-8707-8120
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01 AR071358, R21 OD026618)
Article History
Received: 4 May 2022
Accepted: 30 August 2022
First Online: 12 September 2022
Declarations
:
: No human studies were carried out by the authors for this article. All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.
: S.M.Y. is a co-founder of 3Helix, Inc., which commercializes collagen hybridizing peptides. All other authors have no conflicts of interest, financial or otherwise, to disclose.